by admin | Aug 17, 2021 | ISPOR Values & Outcomes SPOTLIGHT
Our Director at Lucid Health Consulting, George Papadopoulos, edited the ISPOR, Research RoundUp in the July – August 2021 Edition of the Value & Outcomes Spotlight. The latest issue of ISPOR’s Values & Outcomes Spotlight looks at the area of aging. We...
by admin | Feb 26, 2021 | ISPOR Values & Outcomes SPOTLIGHT
Our Director at Lucid Health Consulting, George Papadopoulos, edited the ISPOR, Research RoundUp in the January – February 2021 Edition of the Value & Outcomes Spotlight. The latest issue of ISPOR’s Values & Outcomes Spotlight looks at vaccine hesitancy...
by George Papadopoulos | Dec 21, 2020 | ISPOR Values & Outcomes SPOTLIGHT
Our Director at Lucid Health Consulting, George Papadopoulos, authored the ISPOR, Research RoundUp in the November-December 2020 Edition of the Value & Outcomes Spotlight. The articles in this session of Research Roundup look at precision medicine. Precision...
by George Papadopoulos | Oct 27, 2020 | ISPOR Values & Outcomes SPOTLIGHT
Our Director, George Papadopoulos, authored the ISPOR, Research Roundup in the September-October 2020 Edition of the Value & Outcomes Spotlight. The articles featured in this issue’s Research Round-Up look at the current state of real-world evidence (RWE)....
by George Papadopoulos | Sep 1, 2020 | ISPOR Values & Outcomes SPOTLIGHT
Our Director, George Papadopoulos, authored the ISPOR Research Roundup in the July-August 2020 Edition of the Value & Outcomes Spotlight. George’s article identifies the interface between experimental and behavioural economics and health economics by identifying...
by George Papadopoulos | Jul 1, 2020 | ISPOR Values & Outcomes SPOTLIGHT
Our Director, George Papadopoulos, authored the ISPOR Research Roundup in the May-June 2020 Edition of the Value & Outcomes Spotlight. George’s article identifies recent research publications that highlight innovative pricing models for pharmaceuticals and/or...
Recent Comments